Skip header and navigation

1 records – page 1 of 1.

[Cost-effectiveness analysis of treatment for end-stage renal disease].

https://arctichealth.org/en/permalink/ahliterature146838
Source
Laeknabladid. 2009 Nov;95(11):747-53
Publication Type
Article
Date
Nov-2009
Author
Tinna Laufey Asgeirsdóttir
Gyda Asmundsdóttir
María Heimisdóttir
Eiríkur Jónsson
Runólfur Pálsson
Author Affiliation
Lanspítala Eiríksgötu 5, 105 Reykjavík, Iceland.
Source
Laeknabladid. 2009 Nov;95(11):747-53
Date
Nov-2009
Language
Icelandic
Geographic Location
Denmark
Iceland
Publication Type
Article
Keywords
Cost-Benefit Analysis
Denmark - epidemiology
Health Care Costs
Humans
Iceland - epidemiology
Kidney Failure, Chronic - economics - mortality - therapy
Kidney Transplantation - economics
Living Donors
Models, Economic
Outcome and Process Assessment (Health Care) - economics
Quality of Life
Quality-Adjusted Life Years
Renal Dialysis - economics
Treatment Outcome
Abstract
End-stage renal disease (ESRD) requires costly life-sustaining therapy, either dialysis or kidney transplantation. The purpose of this study was to analyse and compare the cost-effectiveness of kidney transplantation and dialysis in Iceland.
Costs and effectiveness were assessed using the clinical records of the Division of Nephrology patient registration and billing systems and at Landspitali University Hospital, information from the Icelandic Health Insurance on payments for kidney transplantation at Rigshospitalet in Copenhagen, and published studies on survival and quality of life among patients with ESRD. All costs are presented at the 2006 price level and discounting was done according to the lowest interest rate of the Icelandic Housing Finance Fund in that year.
The cost associated with live donor kidney transplantation was greater in Denmark than at LUH, ISK 6.758.101 and ISK 5.442.763, respectively. The cost per quality-adjusted life year gained by live donor kidney transplantation was approximately ISK 2.5 million compared to ISK 10.7 million for dialysis.
The cost of live donor kidney transplantation is within the range generally considered acceptable for life-sustaining therapies. The transplant surgery is less expensive in Iceland than in Denmark. Increasing the number of kidney transplants is cost-effective in light of the lower cost per life-year gained by kidney transplantation compared to dialysis.
Notes
Comment In: Laeknabladid. 2009 Nov;95(11):74319996461
PubMed ID
19996463 View in PubMed
Less detail